Floatz logo

Naltrexone

Complex Regional Pain Syndrome Type 2

Hospital for Special Surgery, New YorkSmall moleculePhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Complex Regional Pain Syndrome Type 2 cohort.

Asset / SponsorPhaseRating
Etoricoxib
Ruhr University of Bochum
Phase 2CCC
Fulranumab
Janssen Research & Development, LLC
Phase 2C
Neurotropin
National Institute of Nursing Research (NINR)
Phase 2NR
Incobotulinumtoxin-A
Bo Biering-Soerensen
N/ANR

Same molecule, other indications

Naltrexone is also rated in:

alcohol dependenceActive
BBB
Indicative · Phase 4
79 / 100
View asset →
osteoarthritisDormant
BBB
Indicative · Phase 4
75 / 100
View asset →
rheumatoid arthritisActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →